Cancer Care Northwest_2 (605 E. Holland) — Spokane, Washington

Cancer Care Northwest_2 (605 E. Holland) is a clinical research site located in Spokane, Washington, United States 99218.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Cancer Care Northwest_2 (605 E. Holland) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm.

Sponsors: BriaCell Therapeutics Corporation.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cancer Care Northwest_2 (605 E. Holland)?

Cancer Care Northwest_2 (605 E. Holland) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cancer Care Northwest_2 (605 E. Holland) conducted?

Cancer Care Northwest_2 (605 E. Holland) has 1 clinical trials on record, with 1 currently active. Their work covers Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm.

Is Cancer Care Northwest_2 (605 E. Holland) accredited by Crixeo Health?

Cancer Care Northwest_2 (605 E. Holland) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cancer Care Northwest_2 (605 E. Holland)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.